Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Sorafenib

Sorafenib

Inquiry
  Post Date: Nov 21,2024
  Expiry Date: May 20,2025
  Detailed Description: Cas No. :284461-73-0 sorafenib;4-(4-((4-chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)-n-methyl-pyridine-2-carboxamide

  CAS Registry Number:

284461-73-0
  Synonyms: ;4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide;4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate;Sorafenib base;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea;4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-Pyridinecarboxamide;
  Molecular Formula: C28H24ClF3N4O6S
  Molecular Weight: 637.0266
  Molecular Structure: 284461-73-0 Sorafenib

  Company: Nanjing CHICO pharmaceutical Co.,Ltd     [ China ]          
  Contact: Mr WU
  Tel: +86-25-84351604
  Fax: +86-25-52261140
  Email: sales@chicopharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.